Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Jan 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1920451000001112 | Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1920461000001110 | Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials | Has dispensed dose form | Conventional release suspension for injection | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | suspensioninjection.intramuscular ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Intramuscular route | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials | VMP prescribing status (attribute) | Never valid to prescribe as a VMP | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials | Is a | COVID-19 vaccine | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials 10 dose | Has VMP | True | Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials | Inferred relationship | Existential restriction modifier | |
| COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca AB) | Is a | True | Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR